Quick Answer
INTENSITY THERAPEUTICS, INC. reported Stockholders Equity of $11.88 million for the year ending 2025.
- INTENSITY THERAPEUTICS, INC. showed an increase of +307.0% in Stockholders Equity from 2024 to 2025.
- This data is from INTENSITY THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: -$10.78 million | Q2 2022: -$12.48 million | Q3 2022: -$14.21 million | Q1 2023: -$15.96 million | Q2 2023: $15.13 million | Q3 2023: $15.91 million | Q1 2024: $9.72 million | Q2 2024: $5.35 million | Q3 2024: $2.78 million | Q1 2025: $334.0 thousand | Q2 2025: $2.18 million | Q3 2025: $7.22 million.
- Over the full 5 years of available data (2021 to 2025), INTENSITY THERAPEUTICS, INC.'s Stockholders Equity has grown by 236.7%.
- Historical annual values: Fiscal year 2025: $11.88 million | Fiscal year 2024: $2.92 million | Fiscal year 2023: $13.16 million | Fiscal year 2022: -$15.10 million | Fiscal year 2021: -$8.69 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: